MGTX - MeiraGTx Holdings plc
NEXT EARNINGS:
Mar 12, 2026
(in 15 days)
EPS Est: $-0.60
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$18.00
DETAILS
HIGH:
$20.00
LOW:
$16.00
MEDIAN:
$18.00
CONSENSUS:
$18.00
UPSIDE:
133.77%
Market Cap:
619.78M
Volume:
318,581
Avg Volume:
486,758
52 Week Range:
4.55-9.73
Sector:
Healthcare
Industry:
Biotechnology
Beta:
1.38
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
375
IPO Date:
2018-06-08
EPS (TTM):
-2.12
P/E Ratio:
-2.88
Revenue (TTM):
33.28M
Total Assets:
269.75M
Total Debt:
84.80M
Cash & Equiv:
103.66M
Rev Growth (5Y):
20.1%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-64.4%
Debt/Equity:
1.25
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-13 | $-0.62 | $-0.50 | -24.0% | $410000 | $3.9M | -89.4% |
| 2025-08-14 | $-0.48 | $-0.52 | +7.7% | $3.7M | $6.5M | -43.1% |
| 2025-05-13 | $-0.51 | $-0.38 | -34.2% | $1.9M | $4.4M | -56.6% |
| 2025-03-13 | $-0.50 | $-0.48 | -4.2% | $21.4M | $1.5M | +1326.0% |
| 2024-11-13 | $-0.54 | $-0.47 | -14.9% | $10.9M | $1.6M | +573.5% |
| 2024-08-12 | $-0.76 | $-0.31 | -145.2% | $282000 | $9.7M | -97.1% |
| 2024-05-09 | $-0.77 | $-0.32 | -140.6% | $697000 | $9.7M | -92.8% |
| 2024-03-14 | $-0.47 | $-0.46 | -2.2% | $2.0M | $6.6M | -68.9% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 33.28M | 14.02M | 15.92M | 37.70M | 15.56M | 13.29M | 0 | 0 | 0 |
| Net Income | (147.79M) | (84.03M) | (129.62M) | (79.56M) | (57.99M) | (54.75M) | (82.87M) | (31.04M) | (19.49M) |
| EPS | -2.12 | -1.49 | -3.16 | -1.63 | -1.43 | -1.58 | -4.37 | -3.62 | -1.01 |
| Total Assets | 269.75M | 326.74M | 318.24M | 320.16M | 363.70M | 323.89M | 96.89M | 25.85M | 22.55M |
| Total Debt | 84.80M | 89.26M | 92.25M | 23.73M | 22.25M | 23.18M | 34,296 | 1.51M | 11,473 |
| Cash & Equivalents | 103.66M | 129.57M | 115.52M | 137.70M | 209.52M | 227.23M | 68.08M | 8.55M | 17.48M |
| Operating Cash Flow | (104.50M) | (105.36M) | (73.10M) | (10.53M) | (63.97M) | 20.04M | (58.89M) | (18.06M) | (14.37M) |
| Free Cash Flow | (109.45M) | (125.54M) | (118.06M) | (65.75M) | (100.99M) | 11.06M | (70.15M) | (28.59M) | (16.96M) |
| FCF per Share | -1.57 | -2.22 | -2.61 | -1.49 | -2.68 | 0.33 | -3.70 | -3.34 | -0.88 |
| Book Value | 67.83M | 138.18M | 117.74M | 185.40M | 238.56M | 190.80M | 81.06M | (47.37M) | (17.14M) |
| Cash & ST Investments | 103.66M | 129.57M | 115.52M | 137.70M | 209.52M | 227.23M | 68.08M | 8.55M | 17.48M |
| ROC Equity | -2.18 | -0.61 | -1.10 | -0.43 | -0.24 | -0.29 | -1.02 | N/A | N/A |